Cerebrospinal fluid 7-ketocholesterol level is associated with amyloid-β42 and white matter microstructure in cognitively healthy adults

Manuscript Number: 

20-0105R1

Author(s): 
Beatriz Abad-García, Maria Arriba, Arantzazu Arrospide, Sara Aurtenetxe, Myriam Barandiaran, Kaj Blennow, Montserrat Clerigue, Irundika H.K. Dias, Mirian Ecay-Torres, Ainara Estanga, Alazne Gabilondo, Maite García-Sebastian, Felix M. Goñi, Ane Iriondo, Andrea Izagirre, Javier Mar, Pablo Martínez-Lage, Jon Saldias, Mikel Tainta, Jorge Villanua, Henrik Zetterberg

Disclosures

Beatriz Abad-García

  • Nothing to Disclose

Maria Arriba

  • Nothing to Disclose

Arantzazu Arrospide

  • Nothing to Disclose

Sara Aurtenetxe

  • Nothing to Disclose

Myriam Barandiaran

  • Nothing to Disclose

Kaj Blennow

  • Consulting Fees:
    served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, Julius Clinical, Lilly, MagQu, Novartis, Roche Diagnostics, and Siemens Healthineers
    Patents/Royalties
    co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program.

Montserrat Clerigue

  • Nothing to Disclose

Irundika H.K. Dias

  • Nothing to Disclose

Mirian Ecay-Torres

  • Nothing to Disclose

Ainara Estanga

  • Nothing to Disclose

Alazne Gabilondo

  • Nothing to Disclose

Maite García-Sebastian

  • Nothing to Disclose

Felix M. Goñi

  • Nothing to Disclose

Ane Iriondo

  • Nothing to Disclose

Andrea Izagirre

  • Nothing to Disclose

Javier Mar

  • Grants
    • Agency: 
      Nutricia
      Dates: 
      2019/06/01 to 2020/12/31

Pablo Martínez-Lage

  • Consulting Fees:
    I have received honoraries for participation in advisory boards from Roche, Biogen, Nutricia, and Esteve
    Lecture Fees:
    I have received honoraries for giving lectures from Roche, Nutricia, and Pfizer

Jon Saldias

  • Sponsors:
    study coordinator and study nurse

Mikel Tainta

  • Nothing to Disclose

Jorge Villanua

  • Nothing to Disclose

Henrik Zetterberg

  • Consulting Fees:
    HZ has served at scientific advisory boards for Roche Diagnostics, Samumed, CogRx and Wave.
    Equity:
    HZ is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg.
    Lecture Fees:
    HZ has given lectures in symposia sponsored by Alzecure and Biogen.